UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Gynecologic cancers and solid organ transplantation

American journal of transplantation, 2019-05, Vol.19 (5), p.1266-1277

2019

Volltextzugriff (PDF)

Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer

Journal of Gynecologic Oncology, 2017, 28(6), , pp.1-10

2017

Volltextzugriff (PDF)

Route of hysterectomy and surgical outcomes from a statewide gynecologic oncology population: is there a role for vaginal hysterectomy?

American journal of obstetrics and gynecology, 2016-03, Vol.214 (3), p.348.e1-348.e9

2016

Volltextzugriff (PDF)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer

Journal for immunotherapy of cancer, 2023-06, Vol.11 (6), p.e006624

2023

Volltextzugriff (PDF)

Vaginal cuff dehiscence after robotic total laparoscopic hysterectomy

Obstetrics and gynecology (New York. 1953), 2009-08, Vol.114 (2 Pt 1), p.369-371

2009

Volltextzugriff (PDF)

Immunotherapy for gynecologic cancers

Gynecologic oncology, 2016-07, Vol.142 (1), p.3-5

Liao, John B

2016

Volltextzugriff (PDF)

Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates

Journal for immunotherapy of cancer, 2021-09, Vol.9 (9), p.e003122

2021

Volltextzugriff (PDF)

Elevated tumor mutational burden and prolonged clinical response to anti-PD-L1 antibody in platinum-resistant recurrent ovarian cancer

Gynecologic oncology reports, 2017-08, Vol.21 (C), p.78-80

2017

Volltextzugriff (PDF)

Clinical predictors of bevacizumab-associated gastrointestinal perforation

Gynecologic oncology, 2011-03, Vol.120 (3), p.464-469

2011

Volltextzugriff (PDF)

Identification of Prognostic Factors in Advanced Epithelial Ovarian Carcinoma

Gynecologic oncology, 2001-09, Vol.82 (3), p.532-537

2001

Volltextzugriff (PDF)

Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers

Journal of Gynecologic Oncology, 2016, 27(5), , pp.1-10

2016

Volltextzugriff (PDF)

Novel Therapeutics for Ovarian Cancer: The 11th Biennial Rivkin Center Ovarian Cancer Research Symposium

International journal of gynecological cancer, 2017-11, Vol.27 (9S Suppl 5), p.S14-S19

2017

Volltextzugriff (PDF)

Vaginal intraepithelial neoplasia (VAIN) after radiation therapy for gynecologic malignancies: A clinically recalcitrant entity

Gynecologic oncology, 2011-01, Vol.120 (1), p.108-112

2011

Volltextzugriff (PDF)

The emergence of immunomodulation: Combinatorial immunochemotherapy opportunities for the next decade

Gynecologic oncology, 2010-02, Vol.116 (2), p.222-233

2010

Volltextzugriff (PDF)

Tumor infiltrating lymphocytes and homologous recombination deficiency are independently associated with improved survival in ovarian carcinoma

Gynecologic oncology, 2019-05, Vol.153 (2), p.217-222

2019

Volltextzugriff (PDF)

Single-Dose, Therapeutic Vaccination of Mice with Vesicular Stomatitis Virus Expressing Human Papillomavirus Type 16 E7 Protein

Clinical and Vaccine Immunology, 2008-05, Vol.15 (5), p.817-824

2008

Volltextzugriff (PDF)

Combining a symptom index, CA125 and HE4 (triple screen) to detect ovarian cancer in women with a pelvic mass

Gynecologic oncology, 2017-11, Vol.147 (2), p.291-295

2017

Volltextzugriff (PDF)

Immunization with a Plasmid DNA Vaccine Encoding the N-Terminus of Insulin-like Growth Factor Binding Protein-2 in Advanced Ovarian Cancer Leads to High-level Type I Immune Responses

Clinical cancer research, 2021-12, Vol.27 (23), p.6405-6412

2021

Volltextzugriff (PDF)

Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancer

Gynecologic oncology, 2024-12, Vol.191, p.74-79

2024

Volltextzugriff (PDF)

Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms: Clinical correlates

Gynecologic oncology, 2015-06, Vol.137 (3), p.430-435

2015

Volltextzugriff (PDF)

Therapeutic vaccines for ovarian cancer

Gynecologic oncology, 2013-09, Vol.130 (3), p.667-673

2013

Volltextzugriff (PDF)

Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study

European journal of gynaecological oncology, 2023-02, Vol.44 (1), p.17-25

2023

Volltextzugriff (PDF)

Phase II trial of albumin-bound paclitaxel and granulocyte macrophage colony-stimulating factor as an immune modulator in recurrent platinum resistant ovarian cancer

Gynecologic oncology, 2017-03, Vol.144 (3), p.480-485

2017

Volltextzugriff (PDF)

Viruses and human cancer

The Yale journal of biology & medicine, 2006-12, Vol.79 (3-4), p.115-122

Liao, John B

2006

Volltextzugriff (PDF)

Uterine lavage identifies cancer mutations and increased TP53 somatic mutation burden in individuals with ovarian cancer

Cancer research communications, 2022-10, Vol.2 (10), p.1282-1292

2022

Volltextzugriff (PDF)

1 – 25 von 476

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(436)
Mit Volltextzugriff
(400)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(473)
Koreanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(352)
Life Sciences & Biomedicine
(279)
Humans
(225)
Female
(123)
Male
(89)
Middle Aged
(68)
Adult
(67)
Animals
(67)
Oncology
(65)
Biological And Medical Sciences
(64)
Aged
(48)
Medical Sciences
(45)
Physical Sciences
(40)
Technology
(38)
Mutation
(32)
Risk Factors
(32)
Science & Technology - Other Topics
(32)
Biochemistry & Molecular Biology
(31)
Fundamental And Applied Biological Sciences. Psychology
(27)
Multidisciplinary Sciences
(26)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Gynecologic cancers and solid organ transplantation

Surgical and oncologic outcomes after robotic radical hysterectomy as compared to open radical hysterectomy in the treatment of early cervical cancer

Route of hysterectomy and surgical outcomes from a statewide gynecologic oncology population: is there a role for vaginal hysterectomy?

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gynecologic cancer

Vaginal cuff dehiscence after robotic total laparoscopic hysterectomy

Immunotherapy for gynecologic cancers

Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates

Elevated tumor mutational burden and prolonged clinical response to anti-PD-L1 antibody in platinum-resistant recurrent ovarian cancer

Clinical predictors of bevacizumab-associated gastrointestinal perforation

Identification of Prognostic Factors in Advanced Epithelial Ovarian Carcinoma

Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers

Novel Therapeutics for Ovarian Cancer: The 11th Biennial Rivkin Center Ovarian Cancer Research Symposium

Vaginal intraepithelial neoplasia (VAIN) after radiation therapy for gynecologic malignancies: A clinically recalcitrant entity

The emergence of immunomodulation: Combinatorial immunochemotherapy opportunities for the next decade

Tumor infiltrating lymphocytes and homologous recombination deficiency are independently associated with improved survival in ovarian carcinoma

Single-Dose, Therapeutic Vaccination of Mice with Vesicular Stomatitis Virus Expressing Human Papillomavirus Type 16 E7 Protein

Combining a symptom index, CA125 and HE4 (triple screen) to detect ovarian cancer in women with a pelvic mass

Immunization with a Plasmid DNA Vaccine Encoding the N-Terminus of Insulin-like Growth Factor Binding Protein-2 in Advanced Ovarian Cancer Leads to High-level Type I Immune Responses

Intraperitoneal immunotherapy with denileukin diftitox (ONTAK) in recurrent refractory ovarian cancer

Detection of the HE4 protein in urine as a biomarker for ovarian neoplasms: Clinical correlates

Therapeutic vaccines for ovarian cancer

Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study

Phase II trial of albumin-bound paclitaxel and granulocyte macrophage colony-stimulating factor as an immune modulator in recurrent platinum resistant ovarian cancer

Viruses and human cancer

Uterine lavage identifies cancer mutations and increased TP53 somatic mutation burden in individuals with ovarian cancer

Suchergebnisse filtern